Search results
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
Zacks via Yahoo Finance· 1 day agoInsulet Corp. PODD recently announced positive results from its Omnipod 5 Automated Insulin Delivery...
Dow Jones Falls, But Nvidia Rebounds, Novo Nordisk Clears Key Level; Tesla Cybertruck Recall
Investor's Business Daily· 1 hour agoThe major indexes were mixed Tuesday as Nvidia and AI stocks rebounded. Novo Nordisk flashed a buy...
Medtronic’s study shows reduced diabetes burden with MiniMed 780G system
Medical Device Network via Yahoo Finance· 1 day agoMedtronic has reported positive results from a study of its MiniMed 780G automated insulin delivery...
How the Ozempic hormone works – and ways to boost it naturally
The Telegraph via Yahoo News· 9 hours agoThey have been the-most-talked-about drugs of the last decade, maybe even the century. The new...
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
Morningstar· 3 hours agoDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new studies presented this past weekend at the 84th Annual American ...
Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes
US News & World Report· 6 hours agoAn experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients, early clinical trial results show. Seven out of 12 ...
Intermittent fasting may help type 2 diabetics control blood sugar - study
Euronews via Yahoo News· 1 day agoIntermittent fasting may help people with early type 2 diabetes improve their blood sugar levels,...
Experts Advise on Early-Risk Monitoring for Type 1 Diabetes
Medscape· 1 day agoA new international consensus statement offers guidance for primary care and endocrinology providers...
SELECT: Semaglutide Reduces CV Events and Diabetes Risk
Medscape· 2 days agoThe glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced...
Novo Nordisk shares results from trial of semaglutide for type 2 diabetes and CKD
Clinical Trials Arena via Yahoo Finance· 7 hours agoDanish pharmaceutical company Novo Nordisk has reported full results from the Phase III FLOW...